ALDVI — Advicenne SA Share News
0.000.00%
Last trade - 00:00- €15.83m
- €33.49m
- €6.01m
Brief: Advicenne Receives Health Canada Clearance To Extend Its Pivotal Phase III Trial Of Adv7103 In Canada
Brief: Advicenne H1 Net Loss Widens To 3.8 Million Euros
Brief: Primex Pharmaceuticals Acquires Rights To Ozalin From Advicenne
Brief: Advicenne Announces FDA Clearance Of IND To Commence Pivotal Phase 3 Trial Of Adv7103
Brief: Advicenne Enters Into Partnership With European Society For Paediatric Nephrology (Espn)
Brief: Advicenne FY Operating Loss Widens To 6.0 Million Euros
Brief: Advicenne Raises 27 Million Euros In IPO On Euronext Paris